Bank of America
LBRX

Bank of America’s LB Pharmaceuticals LBRX Stock Holding History

Bank of America’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Sell
16,618
-27,140
-62% -$626K ﹤0.01% 5004
2025
Q4 		$974K Buy
43,758
+42,058
+2,474% +$735K ﹤0.01% 4543
2025
Q3 		$26.8K Buy
+1,700
New +$27K ﹤0.01% 7006

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of America's LBRX Position: Q1 2026 in Review

Bank of America reduced its LB Pharmaceuticals (LBRX) stake by 62% in Q1 2026, selling an estimated $626K and leaving 16,618 shares worth $410K. The position accounts for ﹤0.01% of the portfolio, ranked #5004.

Bank of America first reported a position in LBRX in Q3 2025 and has held it in 3 quarters since. The position peaked at $974K in Q4 2025. 77 funds tracked by Wall St. Rank hold LBRX as of Q1 2026.

  • Bank of America held 16,618 shares of LB Pharmaceuticals worth $410K as of Q1 2026.
  • Bank of America sold 27,140 LB Pharmaceuticals shares in Q1 2026, an estimated $626K.
  • LB Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5004 holding.
  • Bank of America first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Bank of America's LB Pharmaceuticals position peaked at $974K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.